Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Lipodystrophy news

Show

From To
Lipodystrophy treatment under investigation by US Attorney

Serono, manufacturer of the human growth hormone drug Serostim, is being investigated by the U.S. Attorney's office for possible improper billing and inducements to sell

Published
10 May 2002
By
Edwin J. Bernard
Rosiglitazone loses its lustre: Data on HAART-associated lipodystrophy not encouraging

At the close of the Ninth Annual Retroviruses Conference in Seattle today, researchers from Helsinki presented data from the first controlled study to evaluate the

Published
01 March 2002
By
Anna Poppa
Raised blood pressure more common in lipodystrophy

Raised blood pressure is more common in HIV-positive people with lipodystrophy than either the general population or people with HIV without lipodystrophy, and tended to

Published
06 November 2001
By
Keith Alcorn
How does insulin affect lipodystrophy?

The first day of the Third International Worskhop on Adverse Drug Reactions and Lipodystrophy in Athens was largely devoted to research into insulin resistance –

Published
24 October 2001
By
Keith Alcorn
Lipodystrophy may be less common than thought

Body fat changes that occur after beginning antiretroviral treatment may be less frequent than some experts think, according to findings from two recent studies. Although

Published
03 April 2001
By
Keith Alcorn
British HIV Association adult antiretroviral treatment guidelines: Lipodystrophy

Introduction It is now over 2 years since the widespread recognition of the metabolic and morphologic changes observed during antiretroviral therapy. The characteristic morphological changes observed

Published
17 March 2001
By
Keith Alcorn
Lipodystrophy seen in primary infection HAART patients

Body fat alterations (lipodystrophy) are being seen just one year after individuals with primary HIV infection commence HAART, warned an Australian doctor at the Lisbon

Published
05 March 2001
By
Keith Alcorn
← Prev1...34567Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.